Difference between revisions of "Unfractionated heparin"
Line 25: | Line 25: | ||
==Contraindications== | ==Contraindications== | ||
*Allergy to class/drug | *Allergy to class/drug | ||
− | + | *33% of pts develop some form of bleeding complication; 2-6% develop major bleeding | |
− | + | *Heparin-Induced Thrombocytopenia | |
− | + | *See [[HIT (Heparin-Induced Thrombocytopenia)]] | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
===Risk Factors for Major Bleeding Complication=== | ===Risk Factors for Major Bleeding Complication=== | ||
Line 61: | Line 49: | ||
**Unpredictable anticoagulation effect | **Unpredictable anticoagulation effect | ||
**Must monitor w/ PTT; therapeutic range is 1.5-2.5x normal value | **Must monitor w/ PTT; therapeutic range is 1.5-2.5x normal value | ||
− | |||
==See Also== | ==See Also== | ||
*[[Coagulopathy (Main)]] | *[[Coagulopathy (Main)]] | ||
*[[Low Molecular Weight Heparin]] | *[[Low Molecular Weight Heparin]] | ||
+ | *[[Heparin reversal]] | ||
==Sources== | ==Sources== |
Revision as of 22:56, 17 January 2015
Contents
General
- Type:
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating: Safe in pregnancy
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
- 33% of pts develop some form of bleeding complication; 2-6% develop major bleeding
- Heparin-Induced Thrombocytopenia
- See HIT (Heparin-Induced Thrombocytopenia)
Risk Factors for Major Bleeding Complication
- Recent surgery or trauma
- Renal failure
- Alcoholism
- Malignancy
- Liver failure
- Concurrent use of warfarin, fibrinolytics, steroids, or antiplatelet drugs
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action:
- Binds to and activates antithrombin which in turns inactivates factor Xa and thrombin
- Anticoagulation effect lasts up to 3hr after stopping infusion
- Must give IV (not subq) for acute thromboembolic disease
- Unpredictable anticoagulation effect
- Must monitor w/ PTT; therapeutic range is 1.5-2.5x normal value